Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South Asian Women With Recent Gestational Diabetes
Authors: Nikhil Tandon, Yashdeep Gupta, Deksha Kapoor, Josyula K. Lakshmi, Devarsetty Praveen, Amritendu Bhattacharya, Laurent Billot, Aliya Naheed, Asita de Silva, Ishita Gupta, Noshin Farzana, Renu John, Saumiyah Ajanthan, Hema Divakar, Neerja Bhatla, Ankush Desai, Arunasalam Pathmeswaran, Dorairaj Prabhakaran, Rohina Joshi, Stephen Jan, Helena Teede, Sophia Zoungas, Anushka Patel, Md. Muniruzzaman Siddiqui, Ishrat Jahan, Mohammad Hussain Chowdhury, Md.Faruque Pathan, Bishwajit Bhowmik, Prema Varthakavi, Nikhil Bhagwat, Vaibhavi Mungekar, Rekha Fernandes, Vrinda Pednekar, Nalini Shah, Tushar Bandgar, Swati Jhadav, Arti Utekar, Urjita Ramchandra Sarnobat, Neelam Jaguste, Arti More, Kedar Narvenkar Narvenkar, Guruprasad Padnekar, Ajit Arvind Nagarsenkar, Sachina Vithu Satarkar, Praciya Shyam Goankar, Sneha Chari, Retakshi Ghadi, Nupur Phadte, Mabel Anne Alvares, Mrunali Gaude, Shiwani Dadwal, Sailee Prabhu, Sanjay Bhadada, Neelam Aggarwal, Chandana Datta, Seema Dahiya, Deepak Khandelwal, Soniya Chahal, Renu Mann, Rajiv Singla, Monika Bhatia, Geetu Gupta, Bharti Kharal, Sadishkumar Kamalanathan, Rajan Palui, Jaya Prakash Sahoo, Papa Dasari, Niya Narayan, Varun Suryadevara, Kavi Priya, R Priya, V Mohan, Uma Ram, Guha Pradeepa, Rajasree Gopinath, R Krishnaveni, U Ashwini, E Chandralekha, P Nandhini, Mala Dharmalingam, Chitra Selvan, Pramila Kalra, Mamta Sanjeeva, Dev Sreenivasa, Sowmya G S, Nihal Thomas, Sahana Shetty, Felix Jebasingh, Riddhi Dasgupta, Jiji Mathew, Kavitha Sankar, Jansi Vimala Rani, Nithya Devanithi, Flory Christina, Shirley Newton, Anisha Gala, S Tarakeswari, Vidyavati Patil, M Bhavana Reddy, K Vijayalakshmi, G Vasantha Rani, Sunil Fernando, Carmaline Motha, Sanjeeda Baduge, Sachini Rangana Withanage Withanage, Dilumi Jayawickrama, Saumya Hapuarachchi, Sripali Amarasinghe, Athula Kaluarachchi, MNM Rishad, Sachini Ranasinghe, Madara Jayanetti, Aaisha Azam, Ravija Ramasinghe, H.V.L Rangika, Rukshan  Fernandopulle, Madura Jayawardena, Sheran Siyambalapitiya, Gayan Liyanage, Piyumalie Hettiarachchi, Dimuthu Kaluarachchi, Uthpala Chandradeva, Kalawila Withanage, Rangana Amarasinghe, Deepa Nandani, Jeyakumar  Sabaretnam, Malaka Amarasena, M. D. Radhika Sriyakanthi, Kanchana Peiris, Thiyagarajah Kadotgajan, Milinda Gamlath, Asha Weerasinghe, A.H. Samanthi, Anu Kaushik, Neha Sethi, Ishita Agarwal, Vandana Garg, Kanika Chopra, Divya Soni, Purnima Rao Jevaji, Pavitra Madhira, Thanushanthan Jeevaraja, Shehan Gnanapragasam, Shabnam Sheuly, Nazia Ferdowsh, Tarana Mustari, Shahnaz Parvin Munni, Azmira Khatun, Marzia Sultana, Rifat Hasan Shammi, Sabrina Ahmed, Nantu Chakma, Helen Monaghan, Sindhu Prasad, Amrutha Nagarajaiah, Prakash Velappan, Koushik Gade, Swathi Pagadala, Prithvishree B Radhakrishna, Ambika Yoganathan, Sumathi Senthil, Ravikumar Tummapudi, Ullas Arabhavi, Catherine Lombard, Dewan Alam
Journal: JAMA Network Open (2022)

<h3>Importance</h3> Women with recent gestational diabetes (GDM) have increased risk of developing type 2 diabetes. <h3>Objective</h3> To investigate whether a resource-appropriate and context-appropriate lifestyle intervention could prevent glycemic deterioration among women with recent GDM in South Asia. <h3>Design, Setting, and Participants</h3> This randomized, participant-unblinded controlled trial investigated a 12-month lifestyle intervention vs usual care at 19 urban hospitals in India, Sri Lanka, and Bangladesh. Participants included women with recent diagnosis of GDM who did not have type 2 diabetes at an oral glucose tolerance test (OGTT) 3 to 18 months postpartum. They were enrolled from November 2017 to January 2020, and follow-up ended in January 2021. Data were analyzed from April to July 2021. <h3>Interventions</h3> A 12-month lifestyle intervention focused on diet and physical activity involving group and individual sessions, as well as remote engagement, adapted to local context and resources. This was compared with usual care. <h3>Main Outcomes and Measures</h3> The primary outcome was worsening category of glycemia based on OGTT using American Diabetes Association criteria: (1) normal glucose tolerance to prediabetes (ie, impaired fasting glucose or impaired glucose tolerance) or type 2 diabetes or (2) prediabetes to type 2 diabetes. The primary analysis consisted of a survival analysis of time to change in glycemic status at or prior to the final patient visit, which occurred at varying times after 12 months for each patient. Secondary outcomes included new-onset type 2 diabetes and change in body weight. <h3>Results</h3> A total of 1823 women (baseline mean [SD] age, 30.9 [4.9] years and mean [SD] body mass index, 26.6 [4.6]) underwent OGTT at a median (IQR) 6.5 (4.8-8.2) months postpartum. After excluding 160 women (8.8%) with type 2 diabetes, 2 women (0.1%) who met other exclusion criteria, and 49 women (2.7%) who did not consent or were uncontactable, 1612 women were randomized. Subsequently, 11 randomized participants were identified as ineligible and excluded from the primary analysis, leaving 1601 women randomized (800 women randomized to the intervention group and 801 women randomized to usual care). These included 600 women (37.5%) with prediabetes and 1001 women (62.5%) with normoglycemia. Among participants randomized to the intervention, 644 women (80.5%) received all program content, although COVID-19 lockdowns impacted the delivery model (ie, among 644 participants who engaged in all group sessions, 476 women [73.9%] received some or all content through individual engagement, and 315 women [48.9%] received some or all content remotely). After a median (IQR) 14.1 (11.4-20.1) months of follow-up, 1308 participants (81.2%) had primary outcome data. The intervention, compared with usual care, did not reduce worsening glycemic status (204 women [25.5%] vs 217 women [27.1%]; hazard ratio, 0.92; [95% CI, 0.76–1.12];<i>P</i> = .42) or improve any secondary outcome. <h3>Conclusions and Relevance</h3> This study found that a large proportion of women in South Asian urban settings developed dysglycemia soon after a GDM-affected pregnancy and that a lifestyle intervention, modified owing to the COVID-19 pandemic, did not prevent subsequent glycemic deterioration. These findings suggest that alternate or additional approaches are needed, especially among high-risk individuals. <h3>Trial Registration</h3> Clinical Trials Registry of India Identifier:CTRI/2017/06/008744; Sri Lanka Clinical Trials Registry Identifier:SLCTR/2017/001; and ClinicalTrials.gov Identifier:NCT03305939